These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 23651367)

  • 1. Risks associated with the therapeutic use of fluoroquinolones.
    Stahlmann R; Lode HM
    Expert Opin Drug Saf; 2013 Jul; 12(4):497-505. PubMed ID: 23651367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety considerations of fluoroquinolones in the elderly: an update.
    Stahlmann R; Lode H
    Drugs Aging; 2010 Mar; 27(3):193-209. PubMed ID: 20210367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial safety: focus on fluoroquinolones.
    Owens RC; Ambrose PG
    Clin Infect Dis; 2005 Jul; 41 Suppl 2():S144-57. PubMed ID: 15942881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoroquinolones in the elderly: safety considerations.
    Stahlmann R; Lode H
    Drugs Aging; 2003; 20(4):289-302. PubMed ID: 12641485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicity of quinolones.
    Stahlmann R; Lode H
    Drugs; 1999; 58 Suppl 2():37-42. PubMed ID: 10553703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moxifloxacin: new preparation. A me-too with more cardiac risks.
    Prescrire Int; 2002 Dec; 11(62):168-9. PubMed ID: 12469694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoroquinolones in children: poorly defined risk of joint damage.
    Prescrire Int; 2004 Oct; 13(73):184-6. PubMed ID: 15499700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new respiratory fluoroquinolone, oral gemifloxacin: a safety profile in context.
    Ball P; Mandell L; Patou G; Dankner W; Tillotson G
    Int J Antimicrob Agents; 2004 May; 23(5):421-9. PubMed ID: 15120718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arrhythmias associated with fluoroquinolone therapy.
    Falagas ME; Rafailidis PI; Rosmarakis ES
    Int J Antimicrob Agents; 2007 Apr; 29(4):374-9. PubMed ID: 17241772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety issues and drug-drug interactions with commonly used quinolones.
    Douros A; Grabowski K; Stahlmann R
    Expert Opin Drug Metab Toxicol; 2015 Jan; 11(1):25-39. PubMed ID: 25423877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety profile of the fluoroquinolones.
    Bertino J; Fish D
    Clin Ther; 2000 Jul; 22(7):798-817; discussion 797. PubMed ID: 10945507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety concerns with fluoroquinolones.
    Mehlhorn AJ; Brown DA
    Ann Pharmacother; 2007 Nov; 41(11):1859-66. PubMed ID: 17911203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety profile of moxifloxacin and other fluoroquinolones in special patient populations.
    Iannini PB
    Curr Med Res Opin; 2007 Jun; 23(6):1403-13. PubMed ID: 17559736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QT prolongation and torsade de pointes induced by fluoroquinolones: infrequent side effects from commonly used medications.
    Briasoulis A; Agarwal V; Pierce WJ
    Cardiology; 2011; 120(2):103-10. PubMed ID: 22156660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fluoroquinolones.
    Walker RC
    Mayo Clin Proc; 1999 Oct; 74(10):1030-7. PubMed ID: 10918871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinolones in the aged.
    Nicolle LE
    Drugs; 1999; 58 Suppl 2():49-51. PubMed ID: 10553705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse effects of fluoroquinolones.
    Shimada J; Hori S
    Prog Drug Res; 1992; 38():133-43. PubMed ID: 1609111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of fluoroquinolone treatment on growth of and toxin production by epidemic and nonepidemic clostridium difficile strains in the cecal contents of mice.
    Adams DA; Riggs MM; Donskey CJ
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2674-8. PubMed ID: 17562807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical toxicological aspects of fluoroquinolones.
    Stahlmann R
    Toxicol Lett; 2002 Feb; 127(1-3):269-77. PubMed ID: 12052667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety profile of quinolone antibiotics in the pediatric population.
    Grady R
    Pediatr Infect Dis J; 2003 Dec; 22(12):1128-32. PubMed ID: 14688586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.